drugset / Trial / NCT07818083

The Efficacy and Safety of Tirofiban Enhanced Antiplatelet Therapy in the Treatment of Ruptured Intracranial Aneurysms With Stent

NCT07818083 ↗

Phase 3 Not yet recruiting 622 enrolled First Affiliated Hospital of Fujian Medical University
RandomizedParallel-groupTriple-blindTreatment

Summary

This multicenter prospective randomized controlled study will enroll patients with ruptured intracranial aneurysms receiving stent-assisted coiling across multiple Chinese medical centers. The investigators aim to evaluate the efficacy and safety of tirofiban-enhanced antiplatelet therapy versus conventional dual antiplatelet treatment on the 90-day neurological prognosis and major adverse cerebrovascular events of enrolled subjects.

Timeline

Start
2026-09-01
Primary completion
2028-09-30
Completion
2028-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tirofiban Other / unclassified 0.075 ug/kg Intravenous
Background Aspirin Small molecule 100 mg Oral
Background Clopidogrel Small molecule 75 mg Oral